ISNES, Belgium, March 28, 2019 /PRNewswire/ — VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”) has executed a nonbinding Memorandum of Understanding (“MOU”) with Shanghai Fosun Long March Continue Reading
PRNews
WAT Medical Interviewed by NHK, Japan’s National Broadcasting Organization
VANCOUVER, British Columbia, March 27, 2019 /PRNewswire/ — WAT Medical was recently interviewed by NHK, one of the largest broadcasting corporations in Japan. The interview Continue Reading
EquipNet Raises Fund for Acquisition Strategy as Next Phase in Growth Plan
CANTON, Massachusetts, March 27, 2019 /PRNewswire/ — EquipNet Inc., the global leader in surplus asset management today announced that it has raised an acquisition fund Continue Reading
Shineco, Inc. Receives Regional Government Merchants Invitation for its Industrial Hemp Business Line
BEIJING, March 26, 2019 /PRNewswire/ — Shineco, Inc. (“Shineco” or the “Company”) (NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, specialized Continue Reading
Health2Sync, CTBC Bank and Bitmark Launch World’s First Diabetes Data Trust
-Groundbreaking blockchain trust enhances diabetes research by securing patient medical records, speeding data access and streamlining payments. TAIPEI, Taiwan, March 26, 2019 /PRNewswire/ — Health2Sync, Continue Reading
Ciming Boao International Hospital Fertility Center Begins First Trial Operations
BOAO, China, March 25, 2019 /PRNewswire/ — Ciming Boao International Hospital and Fertility Center, a state-of-the-art 5,000sq meter facility has begun trial operations. Built on Continue Reading
VolitionRx Limited to Present at Conferences in March & April 2019
ISNES, Belgium, March 25, 2019 /PRNewswire/ — VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”) today announced that its Executive Vice President, Investor Relations, Scott Powell, is scheduled to Continue Reading
CStone receives approval in China to initiate Phase 1 clinical trial for RET inhibitor BLU-667 (CS3009)
SUZHOU, China, March 21, 2019 /PRNewswire/ — CStone Pharmaceuticals (“CStone”; HKEX: 2616) today announced that China’s National Medical Products Administration (NMPA) has approved the clinical Continue Reading
Sanofi Chief Executive Officer Olivier Brandicourt attended the China Development Forum and spoke at the Economic Summit
-Showing commitment to help promote the rapid implementation of rare diseases treatment in China BEIJING, March 24, 2019 /PRNewswire/ — Sanofi Chief Executive Officer Olivier Continue Reading
AAHRPP Accredits Three More Research Organizations
Two in the U.S., one in Taiwan attain the gold standard WASHINGTON, March 22, 2019 /PRNewswire/ — The Association for the Accreditation of Human Research Protection Continue Reading